Credentialing

The Parkinson Study Group (PSG) is continually interested in expanding our clinical trial sites as opportunities for new Parkinson’s Disease studies become available. Regardless of location (hospital, community-based, academic, or private practice), the PSG seeks trained Parkinson’s disease investigators who are committed to and experienced in clinical trials.

Congratulations to our newest credentialed PSG members!

Credentialed January 2024

  • Zachary Jordan, MD (The Ohio State University Wexner Medical Center)
  • Jessica Lehosit, DO (Richmond VA Medical Center)
  • Jamie Mark, MS, ARNP (Inland Northwest Research)
  • Mara Seier, MD (University of Nebraska Medical Center)
  • Michael Soileau, MD (Texas Movement Disorder Specialists, PLLC)
  • Diego Torres-Russotto, MD (Baptist Health Miami Neuroscience Institute)

Upcoming Credentialing Deadline​

Quarterly application review:

March 11, 2024

All primary investigators on PSG studies must be credentialed, as well as sub-investigators.

Who Needs to be PSG Credentialed?

All primary investigators on PSG studies must be credentialed, as well as sub-investigators. Our credentialing committee meets quarterly to review all new applications.​​

Upcoming submission deadlines are as follows:

+ March 11, 2024

+ June 10, 2024

+ September 9, 2024

+ December 9, 2024